4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-19-022360
Chief Financial Officer sold 6,318 shares at an average $21.71 ($137,154)
- Chief Financial Officer acquired 6,318 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Viret Jean-Frederic · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-21 | Exercise or conversion : show line 1 in the form | +6,318 | $10.05 | $63,496 | 14,831 | D |
| 2019-08-21 | Sale : show line 2 in the form | −260 | $20.73 | $5,389 | 14,571 | D |
| 2019-08-21 | Sale : show line 3 in the form | −6,058 | $21.75 | $131,766 | 8,513 | D |
| Open-market sales · 6,318 sh · avg $21.71 · $137,154 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-08-21 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,318 | 120,523 | D |
Loading xslF345X03/doc4.xml…